nodes	percent_of_prediction	percent_of_DWPC	metapath
Polymyxin B Sulfate—Caspofungin—SLC22A1—hematologic cancer	0.00694	0.515	CrCbGaD
Polymyxin B Sulfate—Octreotide—MPO—hematologic cancer	0.00451	0.335	CrCbGaD
Polymyxin B Sulfate—Urticaria—Pentostatin—hematologic cancer	0.00253	0.00256	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Anagrelide—hematologic cancer	0.00253	0.00256	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Clofarabine—hematologic cancer	0.00253	0.00256	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Daunorubicin—hematologic cancer	0.00253	0.00256	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Pentostatin—hematologic cancer	0.00252	0.00255	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Anagrelide—hematologic cancer	0.00252	0.00255	CcSEcCtD
Polymyxin B Sulfate—Flushing—Bleomycin—hematologic cancer	0.00251	0.00255	CcSEcCtD
Polymyxin B Sulfate—Thrombophlebitis—Betamethasone—hematologic cancer	0.00251	0.00255	CcSEcCtD
Polymyxin B Sulfate—Thrombophlebitis—Dexamethasone—hematologic cancer	0.00251	0.00255	CcSEcCtD
Polymyxin B Sulfate—Flushing—Vinorelbine—hematologic cancer	0.00247	0.00251	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Busulfan—hematologic cancer	0.00246	0.00249	CcSEcCtD
Polymyxin B Sulfate—Drowsiness—Mitoxantrone—hematologic cancer	0.00245	0.00248	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Idarubicin—hematologic cancer	0.00244	0.00247	CcSEcCtD
Polymyxin B Sulfate—Musculoskeletal stiffness—Methotrexate—hematologic cancer	0.00243	0.00246	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Idarubicin—hematologic cancer	0.00243	0.00246	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Procarbazine—hematologic cancer	0.00241	0.00244	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Procarbazine—hematologic cancer	0.00239	0.00242	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Teniposide—hematologic cancer	0.00237	0.0024	CcSEcCtD
Polymyxin B Sulfate—Pain—Busulfan—hematologic cancer	0.00237	0.0024	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Bexarotene—hematologic cancer	0.00236	0.00239	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Teniposide—hematologic cancer	0.00236	0.00239	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Fludarabine—hematologic cancer	0.00236	0.00239	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Dasatinib—hematologic cancer	0.00234	0.00237	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Bexarotene—hematologic cancer	0.00234	0.00237	CcSEcCtD
Polymyxin B Sulfate—Pain—Procarbazine—hematologic cancer	0.00229	0.00233	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Nelarabine—hematologic cancer	0.00226	0.00229	CcSEcCtD
Polymyxin B Sulfate—Pain—Bexarotene—hematologic cancer	0.00225	0.00228	CcSEcCtD
Polymyxin B Sulfate—Pain—Dasatinib—hematologic cancer	0.00225	0.00228	CcSEcCtD
Polymyxin B Sulfate—Pain—Fludarabine—hematologic cancer	0.00224	0.00227	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Methoxsalen—hematologic cancer	0.00221	0.00224	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Busulfan—hematologic cancer	0.0022	0.00223	CcSEcCtD
Polymyxin B Sulfate—Flushing—Carmustine—hematologic cancer	0.00219	0.00222	CcSEcCtD
Polymyxin B Sulfate—Thrombophlebitis—Prednisone—hematologic cancer	0.00219	0.00222	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Busulfan—hematologic cancer	0.00219	0.00222	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Nilotinib—hematologic cancer	0.00218	0.00221	CcSEcCtD
Polymyxin B Sulfate—Flushing—Alitretinoin—hematologic cancer	0.00217	0.0022	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Imatinib—hematologic cancer	0.00217	0.0022	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Imatinib—hematologic cancer	0.00215	0.00218	CcSEcCtD
Polymyxin B Sulfate—Flushing—Ifosfamide—hematologic cancer	0.00215	0.00218	CcSEcCtD
Polymyxin B Sulfate—Headache—Nelarabine—hematologic cancer	0.00214	0.00217	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Cladribine—hematologic cancer	0.00213	0.00216	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Procarbazine—hematologic cancer	0.00213	0.00216	CcSEcCtD
Polymyxin B Sulfate—Pain—Chlorambucil—hematologic cancer	0.00212	0.00215	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Procarbazine—hematologic cancer	0.00212	0.00215	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Daunorubicin—hematologic cancer	0.00211	0.00214	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Clofarabine—hematologic cancer	0.00211	0.00214	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Cladribine—hematologic cancer	0.00211	0.00214	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Pentostatin—hematologic cancer	0.0021	0.00213	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Anagrelide—hematologic cancer	0.0021	0.00213	CcSEcCtD
Polymyxin B Sulfate—Headache—Methoxsalen—hematologic cancer	0.00209	0.00212	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Dasatinib—hematologic cancer	0.00209	0.00212	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Bexarotene—hematologic cancer	0.00208	0.00211	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Dasatinib—hematologic cancer	0.00208	0.00211	CcSEcCtD
Polymyxin B Sulfate—Pain—Nilotinib—hematologic cancer	0.00208	0.00211	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Fludarabine—hematologic cancer	0.00207	0.0021	CcSEcCtD
Polymyxin B Sulfate—Pain—Imatinib—hematologic cancer	0.00207	0.00209	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Vinblastine—hematologic cancer	0.00204	0.00207	CcSEcCtD
Polymyxin B Sulfate—Flushing—Irinotecan—hematologic cancer	0.00204	0.00207	CcSEcCtD
Polymyxin B Sulfate—Pain—Cladribine—hematologic cancer	0.00203	0.00206	CcSEcCtD
Polymyxin B Sulfate—Caspofungin—ABCB1—hematologic cancer	0.00202	0.15	CrCbGaD
Polymyxin B Sulfate—Headache—Daunorubicin—hematologic cancer	0.002	0.00203	CcSEcCtD
Polymyxin B Sulfate—Headache—Clofarabine—hematologic cancer	0.002	0.00203	CcSEcCtD
Polymyxin B Sulfate—Headache—Pentostatin—hematologic cancer	0.00199	0.00202	CcSEcCtD
Polymyxin B Sulfate—Headache—Anagrelide—hematologic cancer	0.00199	0.00202	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Chlorambucil—hematologic cancer	0.00197	0.002	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Chlorambucil—hematologic cancer	0.00196	0.00199	CcSEcCtD
Polymyxin B Sulfate—Pain—Vinblastine—hematologic cancer	0.00195	0.00197	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Melphalan—hematologic cancer	0.00195	0.00197	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Nilotinib—hematologic cancer	0.00193	0.00196	CcSEcCtD
Polymyxin B Sulfate—Headache—Idarubicin—hematologic cancer	0.00192	0.00195	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Nilotinib—hematologic cancer	0.00192	0.00195	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Imatinib—hematologic cancer	0.00192	0.00195	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Imatinib—hematologic cancer	0.00191	0.00194	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Lenalidomide—hematologic cancer	0.00189	0.00192	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Cladribine—hematologic cancer	0.00189	0.00191	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Cladribine—hematologic cancer	0.00188	0.0019	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Lenalidomide—hematologic cancer	0.00187	0.0019	CcSEcCtD
Polymyxin B Sulfate—Headache—Teniposide—hematologic cancer	0.00187	0.0019	CcSEcCtD
Polymyxin B Sulfate—Pain—Melphalan—hematologic cancer	0.00185	0.00188	CcSEcCtD
Polymyxin B Sulfate—Flushing—Cisplatin—hematologic cancer	0.00185	0.00188	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Hydroxyurea—hematologic cancer	0.00185	0.00187	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Busulfan—hematologic cancer	0.00183	0.00185	CcSEcCtD
Polymyxin B Sulfate—Thrombophlebitis—Methotrexate—hematologic cancer	0.00183	0.00185	CcSEcCtD
Polymyxin B Sulfate—Pain—Lenalidomide—hematologic cancer	0.0018	0.00183	CcSEcCtD
Polymyxin B Sulfate—Pain—Hydroxyurea—hematologic cancer	0.00178	0.0018	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Procarbazine—hematologic cancer	0.00177	0.0018	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Bortezomib—hematologic cancer	0.00174	0.00176	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Bexarotene—hematologic cancer	0.00174	0.00176	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Dasatinib—hematologic cancer	0.00174	0.00176	CcSEcCtD
Polymyxin B Sulfate—Headache—Busulfan—hematologic cancer	0.00173	0.00176	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Bleomycin—hematologic cancer	0.00173	0.00175	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Melphalan—hematologic cancer	0.00172	0.00174	CcSEcCtD
Polymyxin B Sulfate—Thrombophlebitis—Epirubicin—hematologic cancer	0.00171	0.00173	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Vinorelbine—hematologic cancer	0.0017	0.00172	CcSEcCtD
Polymyxin B Sulfate—Flushing—Etoposide—hematologic cancer	0.0017	0.00172	CcSEcCtD
Polymyxin B Sulfate—Headache—Procarbazine—hematologic cancer	0.00168	0.0017	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Lenalidomide—hematologic cancer	0.00167	0.0017	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Lenalidomide—hematologic cancer	0.00166	0.00169	CcSEcCtD
Polymyxin B Sulfate—Pain—Bortezomib—hematologic cancer	0.00166	0.00168	CcSEcCtD
Polymyxin B Sulfate—Headache—Bexarotene—hematologic cancer	0.00165	0.00167	CcSEcCtD
Polymyxin B Sulfate—Headache—Dasatinib—hematologic cancer	0.00165	0.00167	CcSEcCtD
Polymyxin B Sulfate—Pain—Bleomycin—hematologic cancer	0.00164	0.00167	CcSEcCtD
Polymyxin B Sulfate—Headache—Fludarabine—hematologic cancer	0.00164	0.00167	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Hydroxyurea—hematologic cancer	0.00164	0.00166	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Thiotepa—hematologic cancer	0.00162	0.00164	CcSEcCtD
Polymyxin B Sulfate—Pain—Vinorelbine—hematologic cancer	0.00162	0.00164	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Nilotinib—hematologic cancer	0.00161	0.00163	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Thiotepa—hematologic cancer	0.00161	0.00163	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Imatinib—hematologic cancer	0.0016	0.00162	CcSEcCtD
Polymyxin B Sulfate—Thrombophlebitis—Doxorubicin—hematologic cancer	0.00158	0.0016	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Cladribine—hematologic cancer	0.00157	0.00159	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Thalidomide—hematologic cancer	0.00157	0.00159	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Thalidomide—hematologic cancer	0.00155	0.00158	CcSEcCtD
Polymyxin B Sulfate—Pain—Thiotepa—hematologic cancer	0.00155	0.00157	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Bortezomib—hematologic cancer	0.00154	0.00156	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Bortezomib—hematologic cancer	0.00153	0.00155	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Bleomycin—hematologic cancer	0.00153	0.00155	CcSEcCtD
Polymyxin B Sulfate—Headache—Nilotinib—hematologic cancer	0.00152	0.00154	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Bleomycin—hematologic cancer	0.00152	0.00154	CcSEcCtD
Polymyxin B Sulfate—Headache—Imatinib—hematologic cancer	0.00151	0.00153	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Carmustine—hematologic cancer	0.00151	0.00153	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Vinblastine—hematologic cancer	0.00151	0.00153	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Vinorelbine—hematologic cancer	0.0015	0.00152	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Vinorelbine—hematologic cancer	0.0015	0.00152	CcSEcCtD
Polymyxin B Sulfate—Pain—Thalidomide—hematologic cancer	0.00149	0.00152	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Alitretinoin—hematologic cancer	0.00149	0.00151	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Carmustine—hematologic cancer	0.00149	0.00151	CcSEcCtD
Polymyxin B Sulfate—Ataxia—Methotrexate—hematologic cancer	0.00149	0.00151	CcSEcCtD
Polymyxin B Sulfate—Headache—Cladribine—hematologic cancer	0.00149	0.00151	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Alitretinoin—hematologic cancer	0.00148	0.0015	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Ifosfamide—hematologic cancer	0.00148	0.0015	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Ifosfamide—hematologic cancer	0.00146	0.00148	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Vincristine—hematologic cancer	0.00144	0.00146	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Thiotepa—hematologic cancer	0.00144	0.00146	CcSEcCtD
Polymyxin B Sulfate—Pain—Carmustine—hematologic cancer	0.00144	0.00146	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Thiotepa—hematologic cancer	0.00143	0.00145	CcSEcCtD
Polymyxin B Sulfate—Headache—Vinblastine—hematologic cancer	0.00143	0.00145	CcSEcCtD
Polymyxin B Sulfate—Pain—Alitretinoin—hematologic cancer	0.00142	0.00144	CcSEcCtD
Polymyxin B Sulfate—Pain—Ifosfamide—hematologic cancer	0.00141	0.00142	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Irinotecan—hematologic cancer	0.0014	0.00142	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Mitoxantrone—hematologic cancer	0.0014	0.00142	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Lenalidomide—hematologic cancer	0.00139	0.00141	CcSEcCtD
Polymyxin B Sulfate—Ataxia—Epirubicin—hematologic cancer	0.00139	0.00141	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Thalidomide—hematologic cancer	0.00139	0.00141	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Irinotecan—hematologic cancer	0.00139	0.00141	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Mitoxantrone—hematologic cancer	0.00139	0.00141	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Thalidomide—hematologic cancer	0.00138	0.0014	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Hydroxyurea—hematologic cancer	0.00137	0.00139	CcSEcCtD
Polymyxin B Sulfate—Pain—Vincristine—hematologic cancer	0.00137	0.00139	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Gemcitabine—hematologic cancer	0.00137	0.00138	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Gemcitabine—hematologic cancer	0.00135	0.00137	CcSEcCtD
Polymyxin B Sulfate—Pain—Mitoxantrone—hematologic cancer	0.00133	0.00135	CcSEcCtD
Polymyxin B Sulfate—Pain—Irinotecan—hematologic cancer	0.00133	0.00135	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Carmustine—hematologic cancer	0.00133	0.00135	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Alitretinoin—hematologic cancer	0.00132	0.00134	CcSEcCtD
Polymyxin B Sulfate—Headache—Lenalidomide—hematologic cancer	0.00132	0.00134	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Alitretinoin—hematologic cancer	0.00131	0.00133	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Ifosfamide—hematologic cancer	0.00131	0.00132	CcSEcCtD
Polymyxin B Sulfate—Headache—Hydroxyurea—hematologic cancer	0.0013	0.00132	CcSEcCtD
Polymyxin B Sulfate—Pain—Gemcitabine—hematologic cancer	0.0013	0.00132	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Ifosfamide—hematologic cancer	0.0013	0.00132	CcSEcCtD
Polymyxin B Sulfate—Ataxia—Doxorubicin—hematologic cancer	0.00129	0.00131	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Bortezomib—hematologic cancer	0.00128	0.0013	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Cisplatin—hematologic cancer	0.00127	0.00129	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Vincristine—hematologic cancer	0.00127	0.00128	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Vinorelbine—hematologic cancer	0.00125	0.00127	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Mitoxantrone—hematologic cancer	0.00124	0.00126	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Irinotecan—hematologic cancer	0.00123	0.00125	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Mitoxantrone—hematologic cancer	0.00123	0.00125	CcSEcCtD
Polymyxin B Sulfate—Drowsiness—Methotrexate—hematologic cancer	0.00122	0.00124	CcSEcCtD
Polymyxin B Sulfate—Flushing—Prednisone—hematologic cancer	0.00122	0.00123	CcSEcCtD
Polymyxin B Sulfate—Headache—Bortezomib—hematologic cancer	0.00121	0.00123	CcSEcCtD
Polymyxin B Sulfate—Pain—Cisplatin—hematologic cancer	0.00121	0.00123	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Gemcitabine—hematologic cancer	0.0012	0.00122	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Thiotepa—hematologic cancer	0.0012	0.00121	CcSEcCtD
Polymyxin B Sulfate—Headache—Vinorelbine—hematologic cancer	0.00119	0.0012	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Etoposide—hematologic cancer	0.00117	0.00118	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Thalidomide—hematologic cancer	0.00116	0.00117	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Etoposide—hematologic cancer	0.00115	0.00117	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Prednisolone—hematologic cancer	0.00115	0.00117	CcSEcCtD
Polymyxin B Sulfate—Drowsiness—Epirubicin—hematologic cancer	0.00114	0.00116	CcSEcCtD
Polymyxin B Sulfate—Headache—Thiotepa—hematologic cancer	0.00113	0.00115	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Cisplatin—hematologic cancer	0.00112	0.00114	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Carmustine—hematologic cancer	0.00111	0.00113	CcSEcCtD
Polymyxin B Sulfate—Pain—Etoposide—hematologic cancer	0.00111	0.00113	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Alitretinoin—hematologic cancer	0.0011	0.00111	CcSEcCtD
Polymyxin B Sulfate—Headache—Thalidomide—hematologic cancer	0.0011	0.00111	CcSEcCtD
Polymyxin B Sulfate—Pain—Prednisolone—hematologic cancer	0.00109	0.00111	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Ifosfamide—hematologic cancer	0.00109	0.0011	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Vincristine—hematologic cancer	0.00106	0.00107	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Triamcinolone—hematologic cancer	0.00106	0.00107	CcSEcCtD
Polymyxin B Sulfate—Drowsiness—Doxorubicin—hematologic cancer	0.00106	0.00107	CcSEcCtD
Polymyxin B Sulfate—Headache—Carmustine—hematologic cancer	0.00105	0.00107	CcSEcCtD
Polymyxin B Sulfate—Headache—Alitretinoin—hematologic cancer	0.00104	0.00106	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Irinotecan—hematologic cancer	0.00103	0.00105	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Etoposide—hematologic cancer	0.00103	0.00105	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Etoposide—hematologic cancer	0.00103	0.00104	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Prednisolone—hematologic cancer	0.00102	0.00103	CcSEcCtD
Polymyxin B Sulfate—Pain—Triamcinolone—hematologic cancer	0.00101	0.00102	CcSEcCtD
Polymyxin B Sulfate—Headache—Vincristine—hematologic cancer	0.001	0.00102	CcSEcCtD
Polymyxin B Sulfate—Headache—Mitoxantrone—hematologic cancer	0.000978	0.000991	CcSEcCtD
Polymyxin B Sulfate—Headache—Irinotecan—hematologic cancer	0.000978	0.000991	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Dexamethasone—hematologic cancer	0.000959	0.000972	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Betamethasone—hematologic cancer	0.000959	0.000972	CcSEcCtD
Polymyxin B Sulfate—Headache—Gemcitabine—hematologic cancer	0.000952	0.000965	CcSEcCtD
Polymyxin B Sulfate—Flushing—Epirubicin—hematologic cancer	0.000951	0.000964	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Triamcinolone—hematologic cancer	0.000935	0.000948	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Triamcinolone—hematologic cancer	0.000931	0.000944	CcSEcCtD
Polymyxin B Sulfate—Pain—Betamethasone—hematologic cancer	0.000914	0.000926	CcSEcCtD
Polymyxin B Sulfate—Pain—Dexamethasone—hematologic cancer	0.000914	0.000926	CcSEcCtD
Polymyxin B Sulfate—Flushing—Doxorubicin—hematologic cancer	0.00088	0.000892	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Etoposide—hematologic cancer	0.000858	0.00087	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Dexamethasone—hematologic cancer	0.000849	0.00086	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Betamethasone—hematologic cancer	0.000849	0.00086	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Prednisolone—hematologic cancer	0.000847	0.000858	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Dexamethasone—hematologic cancer	0.000845	0.000856	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Betamethasone—hematologic cancer	0.000845	0.000856	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Prednisone—hematologic cancer	0.000835	0.000847	CcSEcCtD
Polymyxin B Sulfate—Headache—Etoposide—hematologic cancer	0.000813	0.000824	CcSEcCtD
Polymyxin B Sulfate—Headache—Prednisolone—hematologic cancer	0.000802	0.000813	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Triamcinolone—hematologic cancer	0.000779	0.000789	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Prednisone—hematologic cancer	0.000739	0.000749	CcSEcCtD
Polymyxin B Sulfate—Headache—Triamcinolone—hematologic cancer	0.000738	0.000748	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Prednisone—hematologic cancer	0.000736	0.000746	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Dexamethasone—hematologic cancer	0.000707	0.000716	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Betamethasone—hematologic cancer	0.000707	0.000716	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Methotrexate—hematologic cancer	0.000698	0.000708	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Methotrexate—hematologic cancer	0.000691	0.000701	CcSEcCtD
Polymyxin B Sulfate—Headache—Dexamethasone—hematologic cancer	0.000669	0.000678	CcSEcCtD
Polymyxin B Sulfate—Headache—Betamethasone—hematologic cancer	0.000669	0.000678	CcSEcCtD
Polymyxin B Sulfate—Pain—Methotrexate—hematologic cancer	0.000665	0.000674	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Epirubicin—hematologic cancer	0.000653	0.000662	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Epirubicin—hematologic cancer	0.000647	0.000656	CcSEcCtD
Polymyxin B Sulfate—Pain—Epirubicin—hematologic cancer	0.000622	0.000631	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Methotrexate—hematologic cancer	0.000618	0.000626	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Prednisone—hematologic cancer	0.000615	0.000624	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Methotrexate—hematologic cancer	0.000615	0.000623	CcSEcCtD
Polymyxin B Sulfate—Paraesthesia—Doxorubicin—hematologic cancer	0.000605	0.000613	CcSEcCtD
Polymyxin B Sulfate—Somnolence—Doxorubicin—hematologic cancer	0.000599	0.000607	CcSEcCtD
Polymyxin B Sulfate—Headache—Prednisone—hematologic cancer	0.000583	0.000591	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Epirubicin—hematologic cancer	0.000578	0.000586	CcSEcCtD
Polymyxin B Sulfate—Pain—Doxorubicin—hematologic cancer	0.000576	0.000584	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Epirubicin—hematologic cancer	0.000575	0.000583	CcSEcCtD
Polymyxin B Sulfate—Urticaria—Doxorubicin—hematologic cancer	0.000535	0.000542	CcSEcCtD
Polymyxin B Sulfate—Body temperature increased—Doxorubicin—hematologic cancer	0.000532	0.00054	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Methotrexate—hematologic cancer	0.000514	0.000521	CcSEcCtD
Polymyxin B Sulfate—Headache—Methotrexate—hematologic cancer	0.000487	0.000494	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Epirubicin—hematologic cancer	0.000481	0.000488	CcSEcCtD
Polymyxin B Sulfate—Headache—Epirubicin—hematologic cancer	0.000456	0.000462	CcSEcCtD
Polymyxin B Sulfate—Dizziness—Doxorubicin—hematologic cancer	0.000445	0.000451	CcSEcCtD
Polymyxin B Sulfate—Headache—Doxorubicin—hematologic cancer	0.000422	0.000428	CcSEcCtD
